A. Satlin

Martin H. Teicher, M H Teicher, H R Lieberman, 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Sleep Disorders in Dementia

A. Satlin, 1994 .

Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody

L. Lannfelt, H. Basun, A. Satlin, 2016, Alzheimer's Research & Therapy.

Head injury, bipolar disorder, and response to valproate.

P. Keck, S. McElroy, H. Pope, 1988, Comprehensive psychiatry.

First-in-human study of E2609, a novel BACE1 inhibitor, demonstrates prolonged reductions in plasma beta-amyloid levels after single dosing

A. Satlin, B. Albala, R. Lai, 2012, Alzheimer's & Dementia.

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

M. Farlow, A. Satlin, J. Yardley, 2011, BMC neurology.

hypertension Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients

Y. Uresin, C. Kilo, A. Satlin, 2008 .

Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension

Y. Uresin, C. Kilo, A. Satlin, 2007, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension

A. Satlin, P. Verdecchia, C. Calvo, 2007, Blood pressure.

Acute Hemodynamic Effects and Tolerability of Phosphodiesterase-1 Inhibition With ITI-214 in Human Systolic Heart Failure

D. Kass, T. Povsic, V. Hahn, 2021, Circulation. Heart failure.

A first-in-human study of BAN2401, a novel monoclonal antibody against beta-amyloid protofibrils

L. Lannfelt, B. Navia, A. Satlin, 2013, Alzheimer's & Dementia.

Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis.

A. Satlin, M. Weir, D. Keefe, 2007, Journal of the American Society of Hypertension : JASH.

Assignment of the gene for human uridine monophosphate kinase to chromosome 1 using somatic cell hybrid clone panels.

R. Kucherlapati, F. Ruddle, A. Satlin, 1975, Cytogenetics and cell genetics.

Cardiac and Hemodynamic Effects of Acute Phosphodiesterase-1 Inhibition in Human Heart Failure

D. Kass, T. Povsic, V. Hahn, 2020 .

ITI-214, A Novel Phosphodiesterase I Inhibitor for the Treatment of Parkinson’s Disease: Results from A Phase I/II Clinical Study (P2.8-051)

G. Snyder, J. Hendrick, L. Wennogle, 2019 .

The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.

L. Lannfelt, A. Satlin, C. Möller, 2014, Journal of Alzheimer's disease : JAD.

Sundown Syndrome in Severely Demented Patients with Probable Alzheimer's Disease

T. Sunderland, J. Little, A. Satlin, 1995, Journal of geriatric psychiatry and neurology.

Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.

G. Zammit, D. Mayleben, A. Satlin, 2017, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.

P. Tariot, S. Salloway, M. Farlow, 2010, Clinical therapeutics.

Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine.

P F Renshaw, P. Renshaw, D. Yurgelun-Todd, 1998, AJNR. American journal of neuroradiology.

Diagnosis of affective disorders in the elderly.

A. Schatzberg, A. Satlin, B. Liptzin, 1984, Psychosomatics.

First-episode mania in late life.

K. Shulman, M. Tohen, A. Satlin, 1994, The American journal of psychiatry.

Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist.

P. Renshaw, W. Offen, A. Satlin, 1997, The American journal of psychiatry.

The significance of mania in old age

K. Shulman, M. Tohen, A. Satlin, 1992 .

Regional cerebral blood volume measured by dynamic susceptibility contrast MR imaging in alzheimer's disease: A principal components analysis

P. Renshaw, C. D. English, R. Lewis, 1997, Journal of magnetic resonance imaging : JMRI.

9.10 Aliskiren, a Novel Renin Inhibitor, Has Greater Blood Pressure Lowering Effect Than Ramipril and Additional Blood Pressure Lowering Effect When Combined with Ramipril in Patients with Diabetes and Hypertension

Y. Uresin, C. Kilo, A. Satlin, 2007 .

Glycopyrrolate Versus Atropine in Post-ECT Amnesia in the Elderly

A. Satlin, B. Sommer, J. Cole, 1989, Journal of geriatric psychiatry and neurology.

Mania compared with unipolar depression in old age.

K. Shulman, M. Tohen, A. Satlin, 1992, The American journal of psychiatry.

Late‐Life Suicide: A Review

A. Bharucha, A. Satlin, Andrew Satlin, 1997, Harvard review of psychiatry.

Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study.

A. Arzimanoglou, A. Satlin, E. Schuck, 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Disturbance of endogenous circadian rhythm in aging and Alzheimer disease.

Ann C McKee, Ladislav Volicer, A. McKee, 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Sundowning and circadian rhythms in Alzheimer's disease.

B. C. Manning, A. Satlin, L. Volicer, 2001, The American journal of psychiatry.

A Double-Blind, Randomized, Multicenter, Dose-Ranging Study to Evaluate the Safety and Efficacy of Fospropofol Disodium as an Intravenous Sedative for Colonoscopy in High-Risk Populations

S. Bergese, K. Candiotti, A. Satlin, 2013, American journal of therapeutics.

Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody

L. Lannfelt, H. Basun, A. Satlin, 2016, Alzheimer's Research & Therapy.

Abnormal erythrocyte anion exchange in Alzheimer disease.

A. K. Solomon, A. Satlin, F. Greco, 2000, Archives of pathology & laboratory medicine.

Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project.

José Luis Molinuevo, Simon Lovestone, Luc Truyen, 2016, The lancet. Psychiatry.

Vitamin B12 and folate status in acute geropsychiatric inpatients: Affective and cognitive characteristics of a vitamin nondeficient population

I. Bell, A. Satlin, B. Liptzin, 1990, Biological Psychiatry.

The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT.

B L Holman, B. Holman, K. Johnson, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia.

E. Stopa, A. Satlin, L. Volicer, 1999, Journal of neuropathology and experimental neurology.

Perspectives on future Alzheimer therapies: amyloid-β protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease

L. Lannfelt, H. Basun, A. Satlin, 2014, Alzheimer's Research & Therapy.

Estrogen therapy and aggressive behavior in elderly patients with moderate-to-severe dementia: results from a short-term, randomized, double-blind trial.

J. Hennen, A. Satlin, H. Kyomen, 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Estrogen Therapy and Aggressive Behavior in Elderly Patients With Moderate-to-Severe Dementia

J. Hennen, A. Satlin, Jeanne Y Wei, 1999 .

Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial

S. Oparil, A. Satlin, Samir Patel, 2007, The Lancet.

Dorsomedial SCN neuronal subpopulations subserve different functions in human dementia.

A. McKee, N. Kowall, E. Stopa, 2008, Brain : a journal of neurology.

Drug Development for Neurodegenerative Diseases Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating

C. Compton, M. Carrillo, B. Corrigan, 2014 .

Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating Drug Development for Neurodegenerative Diseases

C. Jack, C. Compton, M. Carrillo, 2013, Therapeutic innovation & regulatory science.

ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials

Jeffrey Cummings, Suzanne B Hendrix, J. Cummings, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia

C. Correll, A. Satlin, K. Vanover, 2021, Schizophrenia Research.

Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients–Thrombolysis in Myocardial Infarction 61 (CAMELLIA‐TIMI 61) trial

A. Keech, M. Sabatine, B. Scirica, 2018, American heart journal.

Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.

Roland E Schmieder, Andrzej Januszewicz, R. Schmieder, 2007, American journal of hypertension.

Family involvement in treatment of the frail elderly

A. Satlin, 1991 .

Depression in a Long‐Term Care Facility: Clinical Features and Discordance Between Nursing Assessment and Patient Interviews

L. Lipsitz, A. Satlin, C. Salzman, 1995, Journal of the American Geriatrics Society.

Changes in Tardive Dyskinesia Symptoms in Elderly Patients Treated with Ganglioside GM1 or Placebo

B. Cohen, A. Satlin, L. Jandorf, 1994, Journal of geriatric psychiatry and neurology.

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms

David S. Miller, P. Tariot, C. Lyketsos, 2017, Alzheimer's & dementia.

Quantitative brain SPECT in Alzheimer's disease and normal aging.

M F Kijewski, B L Holman, J. Becker, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease

D. Fish, A. McKee, E. Stopa, 2004, Neurobiology of Aging.

Lumateperone (ITI-007) in the Treatment of Bipolar Depression: Results from a Randomized Clinical Trial.

J. Calabrese, S. Durgam, A. Satlin, 2021, CNS spectrums.

P.671 Efficacy and safety of lumateperone tosylate 42mg in the treatment of schizophrenia: A pooled analysis of phase 2 and 3 studies

C. Tamminga, J. Kane, S. Durgam, 2019, European Neuropsychopharmacology.

P.673 Results from a 12-month open-label safety study of lumateperone (ITI-007) in patients with stable symptoms of schizophrenia

C. Correll, S. Durgam, A. Satlin, 2019, European Neuropsychopharmacology.

30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-label Safety Switching Study

A. Satlin, K. Vanover, Robert E Davis, 2019, CNS Spectrums.

F46. LUMATEPERONE (ITI-007): FAVORABLE SAFETY PROFILE IN AN OPEN LABEL SAFETY SWITCHING STUDY FROM STANDARD-OF-CARE ANTIPSYCHOTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA

C. Correll, A. Dmitrienko, A. Satlin, 2018, Schizophrenia Bulletin.

Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration.

A. McKee, E. Stopa, A. Satlin, 2001, Archives of general psychiatry.

Safety and tolerability of lumateperone for the treatment of schizophrenia: a pooled analysis of late-phase placebo- and active-controlled clinical trials

J. Kane, S. Durgam, A. Satlin, 2021, International clinical psychopharmacology.

Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial.

Robert I. Davis, J. Calabrese, G. Sachs, 2021, The American journal of psychiatry.

Treatment of Compulsive Shopping with Antidepressants: a Report of Three Cases

P. Keck, S. McElroy, H. Pope, 1991 .

Regional atrophy of the corpus callosum in subjects with Alzheimer's disease and multi-infarct dementia

In Kyoon Lyoo, Perry F. Renshaw, P. Renshaw, 1997, Psychiatry Research: Neuroimaging.

In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes

P. Renshaw, D. Yurgelun-Todd, A. Satlin, 1997, Biological Psychiatry.

Brain proton magnetic resonance spectroscopy in Alzheimer disease: changes after treatment with xanomeline.

P. Renshaw, L. Wald, J. Hennen, 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Introducing a new tool for optimizing responsiveness to decline in early Alzheimer's disease

S. Hendrix, A. Satlin, C. Perdomo, 2012, Alzheimer's & Dementia.

Rivastigmine in Alzheimer disease: efficacy over two years.

R. Spiegel, A. Satlin, G. Grossberg, 2004, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to <4 years old) with Lennox-Gastaut syndrome: Final results from randomized study 303.

A. Arzimanoglou, A. Satlin, Dinesh Kumar, 2019, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies

Simon Shorvon, Philippe Ryvlin, E. Ben-Menachem, 2013, Epilepsia.

Effects of Passive Body Heating on the Sleep of Older Female Insomniacs

Martin H. Teicher, S. Lukas, J. Winkelman, 1996, Journal of geriatric psychiatry and neurology.

MINI-LOGGER ® Bibliography

Bailey, A. A. Levin, Joan, 2022 .

Development of perampanel in epilepsy

A. Satlin, A. Laurenza, L. Kramer, 2013, Acta neurologica Scandinavica. Supplementum.

A randomized, placebo‐controlled trial of paroxetine in nursing home residents with non‐major depression

B. Pollock, A. Satlin, C. Salzman, 2002, Depression and anxiety.

S-adenosyl-L-methionine in the treatment of Alzheimer's disease.

B. Cohen, A. Satlin, G. Zubenko, 1988, Journal of Clinical Psychopharmacology.